日本高潮视频在线观看-亚洲中文字幕永不卡-精品亚洲一区二区三区-伦理片夜夜躁狠狠躁日日躁-日本最新免费不卡二区-国产精品口爆一区二区三区-av一区二区三区高清-大鸡巴疯狂抽插小穴视频-日韩中文国产在线观看免费视频

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號 規(guī)格
Recombinant Ureaplasma parvum serovar 3 50S ribosomal protein L14 (rplN) CSB-YP874001UAO
CSB-EP874001UAO
CSB-BP874001UAO
CSB-MP874001UAO
CSB-EP874001UAO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ureaplasma parvum serovar 3 50S ribosomal protein L22 (rplV) CSB-YP874002UAO
CSB-EP874002UAO
CSB-BP874002UAO
CSB-MP874002UAO
CSB-EP874002UAO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ureaplasma parvum serovar 3 Translation initiation factor IF-3 (infC) CSB-YP874003UAO
CSB-EP874003UAO
CSB-BP874003UAO
CSB-MP874003UAO
CSB-EP874003UAO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ureaplasma parvum serovar 3 Phosphate acyltransferase (plsX) CSB-YP874004UAO
CSB-EP874004UAO
CSB-BP874004UAO
CSB-MP874004UAO
CSB-EP874004UAO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ureaplasma parvum serovar 3 Ribose-phosphate pyrophosphokinase (prs) CSB-YP874005UAO
CSB-EP874005UAO
CSB-BP874005UAO
CSB-MP874005UAO
CSB-EP874005UAO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ureaplasma parvum serovar 3 Ribosomal RNA large subunit methyltransferase H (rlmH) CSB-YP874006UAO
CSB-EP874006UAO
CSB-BP874006UAO
CSB-MP874006UAO
CSB-EP874006UAO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ureaplasma parvum serovar 3 Uncharacterized protein UU171 (UU171) CSB-YP874007UAO
CSB-EP874007UAO
CSB-BP874007UAO
CSB-MP874007UAO
CSB-EP874007UAO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ureaplasma parvum serovar 3 Uncharacterized protein UU165 (UU165) CSB-YP874008UAO
CSB-EP874008UAO
CSB-BP874008UAO
CSB-MP874008UAO
CSB-EP874008UAO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ureaplasma parvum serovar 3 Uncharacterized protein UU157 (UU157) CSB-YP874009UAO
CSB-EP874009UAO
CSB-BP874009UAO
CSB-MP874009UAO
CSB-EP874009UAO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ureaplasma parvum serovar 3 Uncharacterized protein UU151 (UU151) CSB-YP874010UAO
CSB-EP874010UAO
CSB-BP874010UAO
CSB-MP874010UAO
CSB-EP874010UAO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ureaplasma parvum serovar 3 Uncharacterized protein UU144 (UU144) CSB-YP874011UAO
CSB-EP874011UAO
CSB-BP874011UAO
CSB-MP874011UAO
CSB-EP874011UAO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ureaplasma parvum serovar 3 ATP synthase subunit beta (atpD) CSB-YP874012UAO
CSB-EP874012UAO
CSB-BP874012UAO
CSB-MP874012UAO
CSB-EP874012UAO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ureaplasma parvum serovar 3 Uracil phosphoribosyltransferase (upp) CSB-YP874013UAO
CSB-EP874013UAO
CSB-BP874013UAO
CSB-MP874013UAO
CSB-EP874013UAO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ureaplasma parvum serovar 3 Uncharacterized protein UU101 (UU101) CSB-YP874014UAO
CSB-EP874014UAO
CSB-BP874014UAO
CSB-MP874014UAO
CSB-EP874014UAO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ureaplasma parvum serovar 3 tRNA (Ile)-lysidine synthase (tilS) CSB-YP874015UAO
CSB-EP874015UAO
CSB-BP874015UAO
CSB-MP874015UAO
CSB-EP874015UAO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ureaplasma parvum serovar 3 Uncharacterized protein UU061 (UU061), partial CSB-YP874016UAO
CSB-EP874016UAO
CSB-BP874016UAO
CSB-MP874016UAO
CSB-EP874016UAO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ureaplasma parvum serovar 3 Uncharacterized protein UU049 (UU049) CSB-YP874017UAO
CSB-EP874017UAO
CSB-BP874017UAO
CSB-MP874017UAO
CSB-EP874017UAO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ureaplasma parvum serovar 3 Uncharacterized protein UU035 (UU035) CSB-YP874018UAO
CSB-EP874018UAO
CSB-BP874018UAO
CSB-MP874018UAO
CSB-EP874018UAO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ureaplasma parvum serovar 3 tRNA modification GTPase MnmE (mnmE) CSB-YP874019UAO
CSB-EP874019UAO
CSB-BP874019UAO
CSB-MP874019UAO
CSB-EP874019UAO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ureaplasma parvum serovar 3 50S ribosomal protein L31 (rpmE) CSB-YP874020UAO
CSB-EP874020UAO
CSB-BP874020UAO
CSB-MP874020UAO
CSB-EP874020UAO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時,你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實驗更有可能成功。但是如果你做了錯誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗總結(jié)出了幾個有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://m.bdspa.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價格、交貨、質(zhì)量等,您可以點擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>



×